| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10588659 | Bioorganic & Medicinal Chemistry Letters | 2011 | 5 Pages |
Abstract
TGF-β signaling pathway inhibitor and potential anti-nephropathic agent SMP-534 was successfully converted to a new class of benzoylpyrrole-based PPARα/γ activators as an anti-diabetic agent. Compound 10sNa showed a favorable blood glucose-lowering effect without body weight gain.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Kantaro Ushiroda, Katsunori Maruta, Makoto Kitoh, Kiyotaka Iwai, Jun Nagamine, Atsushi Tsuchida, Mutsuo Taiji, Ryu Nagata,